# Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Versus Valaciclovir

> **NCT05446571** · PHASE3 · RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 46 (estimated)

## Conditions studied

- Pregnant Women
- CMV Infected Fetuses

## Interventions

- **DRUG:** Letermovir
- **DRUG:** Valacyclovir

## Key facts

- **NCT ID:** NCT05446571
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-20
- **Primary completion:** 2029-08
- **Final completion:** 2029-08
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2026-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05446571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05446571, "Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Versus Valaciclovir". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05446571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*